Stock listing
A407RQ Stock Price, News, Filings & Events — Serina Therapeutics, Inc.
Selected listing: A407RQ · LS · EUR · DE
This page tracks Serina Therapeutics, Inc.'s A407RQ:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A407RQ:LS. A407RQ:LS is the stock-level entry point for investors researching Serina Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Serina Therapeutics, Inc. (Ticker: SER) is a public company based in the United States, with a market capitalization of approximately $31.9 million. The company focuses on developing innovative therapeutic solutions. Investors can find more information about Serina Therapeutics and its market activities on its dedicated public company page.

- Ticker
- A407RQ:LS
- Asset type
- Stock
- Market cap
- $56.4M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- LS
- Currency
- EUR
Serina Therapeutics, Inc. A407RQ:LS stock context
This page tracks Serina Therapeutics, Inc.'s A407RQ:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A407RQ:LS. A407RQ:LS is the stock-level entry point for investors researching Serina Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Serina Therapeutics, Inc. (Ticker: SER) is a public company based in the United States, with a market capitalization of approximately $31.9 million. The company focuses on developing innovative therapeutic solutions. Investors can find more information about Serina Therapeutics and its market activities on its dedicated public company page.
Latest news from Serina Therapeutics, Inc.
Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2
September 9, 2026
Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit
April 7, 2026
Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan
April 2, 2026
Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
March 25, 2026
Serina Therapeutics to Present at the 38th Annual Roth Conference
March 24, 2026
Research Serina Therapeutics, Inc.
Serina Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A407RQ:LS.
Serina Therapeutics, Inc. company profile
View the public company page for Serina Therapeutics, Inc. on 6ix.
Serina Therapeutics, Inc. news
Read company news and market updates connected to Serina Therapeutics, Inc..
Serina Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Serina Therapeutics, Inc..
Alternate listings
SER:AMEX
US · USD
Alternate listing for Serina Therapeutics, Inc.; the primary context on this page is A407RQ:LS.
2BO:TRADEGATE
DE · EUR
Alternate listing for Serina Therapeutics, Inc.; the primary context on this page is A407RQ:LS.
SER:BOATS
US · USD
Alternate listing for Serina Therapeutics, Inc.; the primary context on this page is A407RQ:LS.
2BO:GETTEX
DE · EUR
Alternate listing for Serina Therapeutics, Inc.; the primary context on this page is A407RQ:LS.
2BO:FWB
DE · EUR
Alternate listing for Serina Therapeutics, Inc.; the primary context on this page is A407RQ:LS.